260 related articles for article (PubMed ID: 21639880)
1. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
[TBL] [Abstract][Full Text] [Related]
2. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
3. Cystine/glutamate antiporter blockage induces myelin degeneration.
Soria FN; Zabala A; Pampliega O; Palomino A; Miguelez C; Ugedo L; Sato H; Matute C; Domercq M
Glia; 2016 Aug; 64(8):1381-95. PubMed ID: 27247047
[TBL] [Abstract][Full Text] [Related]
4. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.
Lewerenz J; Albrecht P; Tien ML; Henke N; Karumbayaram S; Kornblum HI; Wiedau-Pazos M; Schubert D; Maher P; Methner A
J Neurochem; 2009 Oct; 111(2):332-43. PubMed ID: 19694903
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Martín A; Vázquez-Villoldo N; Gómez-Vallejo V; Padro D; Soria FN; Szczupak B; Plaza-García S; Arrieta A; Reese T; Llop J; Domercq M; Matute C
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1124-38. PubMed ID: 26659901
[TBL] [Abstract][Full Text] [Related]
6. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.
Albrecht P; Lewerenz J; Dittmer S; Noack R; Maher P; Methner A
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):373-82. PubMed ID: 20053169
[TBL] [Abstract][Full Text] [Related]
8. System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo.
Kigerl KA; Ankeny DP; Garg SK; Wei P; Guan Z; Lai W; McTigue DM; Banerjee R; Popovich PG
Exp Neurol; 2012 Jan; 233(1):333-41. PubMed ID: 22079587
[TBL] [Abstract][Full Text] [Related]
9. HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter.
Gupta S; Knight AG; Gupta S; Knapp PE; Hauser KF; Keller JN; Bruce-Keller AJ
Neurosci Lett; 2010 Nov; 485(3):233-6. PubMed ID: 20849923
[TBL] [Abstract][Full Text] [Related]
10. Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat.
La Bella V; Valentino F; Piccoli T; Piccoli F
Neurochem Res; 2007 Jun; 32(6):1081-90. PubMed ID: 17401668
[TBL] [Abstract][Full Text] [Related]
11. Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling.
Bridges R; Lutgen V; Lobner D; Baker DA
Pharmacol Rev; 2012 Jul; 64(3):780-802. PubMed ID: 22759795
[TBL] [Abstract][Full Text] [Related]
12. Glutamate, excitatory amino acid transporters, Xc- antiporter, glutamine synthetase, and gamma-glutamyltranspeptidase in human corneal epithelium.
Langford MP; Redmond P; Chanis R; Misra RP; Redens TB
Curr Eye Res; 2010 Mar; 35(3):202-11. PubMed ID: 20373878
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
14. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
Bridges CC; Kekuda R; Wang H; Prasad PD; Mehta P; Huang W; Smith SB; Ganapathy V
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):47-54. PubMed ID: 11133847
[TBL] [Abstract][Full Text] [Related]
15. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
Savaskan NE; Hahnen E; Eyüpoglu IY
J Cell Physiol; 2009 Aug; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
[No Abstract] [Full Text] [Related]
16. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
17. The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-) : cystine supplier and beyond.
Conrad M; Sato H
Amino Acids; 2012 Jan; 42(1):231-46. PubMed ID: 21409388
[TBL] [Abstract][Full Text] [Related]
18. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.
Lewerenz J; Hewett SJ; Huang Y; Lambros M; Gout PW; Kalivas PW; Massie A; Smolders I; Methner A; Pergande M; Smith SB; Ganapathy V; Maher P
Antioxid Redox Signal; 2013 Feb; 18(5):522-55. PubMed ID: 22667998
[TBL] [Abstract][Full Text] [Related]
19. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.
Domercq M; Sánchez-Gómez MV; Sherwin C; Etxebarria E; Fern R; Matute C
J Immunol; 2007 May; 178(10):6549-56. PubMed ID: 17475885
[TBL] [Abstract][Full Text] [Related]
20. The link between excitotoxic oligodendroglial death and demyelinating diseases.
Matute C; Alberdi E; Domercq M; Pérez-Cerdá F; Pérez-Samartín A; Sánchez-Gómez MV
Trends Neurosci; 2001 Apr; 24(4):224-30. PubMed ID: 11250007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
